Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Plantinga, TS"'
Autor:
Plantinga TS; Department of Internal Medicine, Division of Endocrinology, Radboud University Medical Center, Nijmegen, The Netherlands., Arts P; Department of Human Genetics, Radboud University Medical Center, Nijmegen, The Netherlands., Knarren GH; Department of Internal Medicine, Slingeland Hospital, Doetinchem, The Netherlands., Mulder AH; Department of Internal Medicine, Slingeland Hospital, Doetinchem, The Netherlands., Wakelkamp IM; Department of Internal Medicine, St Antonius Hospital, Nieuwegein, The Netherlands., Hermus AR; Department of Internal Medicine, Division of Endocrinology, Radboud University Medical Center, Nijmegen, The Netherlands., Joosten LA; Department of Internal Medicine, Division of Endocrinology, Radboud University Medical Center, Nijmegen, The Netherlands., Netea MG; Department of Internal Medicine, Division of Endocrinology, Radboud University Medical Center, Nijmegen, The Netherlands., Bisschop PH; Department of Endocrinology and Metabolism, Academic Medical Centre, Amsterdam, The Netherlands., de Herder WW; Department of Internal Medicine, Division of Endocrinology, Erasmus Medical Center, Rotterdam, The Netherlands., Beijers HJ; Department of Internal Medicine, Division of Endocrinology, Radboud University Medical Center, Nijmegen, The Netherlands., de Bruin IJ; Department of Internal Medicine, Division of Endocrinology, Radboud University Medical Center, Nijmegen, The Netherlands., Gilissen C; Department of Human Genetics, Radboud University Medical Center, Nijmegen, The Netherlands., Veltman JA; Department of Human Genetics, Radboud University Medical Center, Nijmegen, The Netherlands., Hoischen A; Department of Human Genetics, Radboud University Medical Center, Nijmegen, The Netherlands., Smit JW; Department of Internal Medicine, Division of Endocrinology, Radboud University Medical Center, Nijmegen, The Netherlands., Netea-Maier RT; Department of Internal Medicine, Division of Endocrinology, Radboud University Medical Center, Nijmegen, The Netherlands.
Publikováno v:
Clinical pharmacology and therapeutics [Clin Pharmacol Ther] 2017 Dec; Vol. 102 (6), pp. 1017-1024. Date of Electronic Publication: 2017 Jul 10.
Autor:
Peter H. Bisschop, Peer Arts, Christian Gilissen, Jan W. A. Smit, W. W. de Herder, IJ de Bruin, Leo A. B. Joosten, Ad R. M. M. Hermus, Joris A. Veltman, HJ Beijers, Theo S. Plantinga, AH Mulder, IM Wakelkamp, Mihai G. Netea, GH Knarren, Romana T. Netea-Maier, Alexander Hoischen
Publikováno v:
Clinical Pharmacology & Therapeutics, 102(6), 1017-1024. Wiley-Blackwell
Clinical Pharmacology and Therapeutics, 102, 6, pp. 1017-1024
Clinical pharmacology and therapeutics, 102(6), 1017-1024. Wiley-Blackwell
Clinical Pharmacology and Therapeutics, 102, 1017-1024
Clinical Pharmacology and Therapeutics, 102, 6, pp. 1017-1024
Clinical pharmacology and therapeutics, 102(6), 1017-1024. Wiley-Blackwell
Clinical Pharmacology and Therapeutics, 102, 1017-1024
Agranulocytosis is a rare and serious adverse effect of antithyroid drugs, with unknown etiology. The present study aimed to uncover genetic susceptibility and underlying mechanisms of antithyroid drug-induced agranulocytosis (ATDAC). We studied two